Quarterly report pursuant to Section 13 or 15(d)

Note 1 - Description of the Business and Liquidity (Details Textual)

v2.4.1.9
Note 1 - Description of the Business and Liquidity (Details Textual) (USD $)
1 Months Ended 3 Months Ended 12 Months Ended
Dec. 31, 2014
Mar. 31, 2014
Mar. 31, 2015
Mar. 31, 2014
Dec. 31, 2014
Dec. 31, 2013
Retained Earnings (Accumulated Deficit) $ (77,277,334)us-gaap_RetainedEarningsAccumulatedDeficit   $ (81,222,588)us-gaap_RetainedEarningsAccumulatedDeficit   $ (77,277,334)us-gaap_RetainedEarningsAccumulatedDeficit  
Net Cash Provided by (Used in) Operating Activities     (2,799,042)us-gaap_NetCashProvidedByUsedInOperatingActivities (1,359,118)us-gaap_NetCashProvidedByUsedInOperatingActivities (7,250,303)us-gaap_NetCashProvidedByUsedInOperatingActivities  
Proceeds from Issuance of Private Placement 9,379,880us-gaap_ProceedsFromIssuanceOfPrivatePlacement 3,503,314us-gaap_ProceedsFromIssuanceOfPrivatePlacement        
Cash and Cash Equivalents, at Carrying Value 9,244,006us-gaap_CashAndCashEquivalentsAtCarryingValue 5,801,050us-gaap_CashAndCashEquivalentsAtCarryingValue 6,438,329us-gaap_CashAndCashEquivalentsAtCarryingValue 5,801,050us-gaap_CashAndCashEquivalentsAtCarryingValue 9,244,006us-gaap_CashAndCashEquivalentsAtCarryingValue 3,516,244us-gaap_CashAndCashEquivalentsAtCarryingValue
Boston Scientific Notes [Member]            
Notes Payable Cancelled, Principal Amount   $ 4,338,601mric_NotesPayableCancelledPrincipalAmount
/ us-gaap_RelatedPartyTransactionAxis
= mric_BostonScientificNotesMember